Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METorMET²: Methotrexate vs Methotrexate + Metformin in Rheumatoid Arthritis
2024-511033-35-00Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Jul 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Methotrexate + Metformin with Methotrexate + Placebo (2 arms). Primary endpoint: Disease activity (DAS28). Started Jul 2024; status: completed.
02
Drugs
methotrexatemetformin
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2024-511033-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511033-35-00.